Histidine Tag (His-Tag) Antibody Market Report 2026

The histidine tag (his-tag) antibody market size has grown rapidly in recent years. It will grow from $1.43 billion in 2025 to $1.6 billion in 2026 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to growth in recombinant protein research, expansion of academic life science laboratories, increasing use of affinity purification techniques, availability of standardized tagging methods, rising funding for molecular biology research.

The histidine tag (his-tag) antibody market size is expected to see rapid growth in the next few years. It will grow to $2.48 billion in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to increasing demand for advanced protein analysis tools, expansion of biopharmaceutical research pipelines, growing adoption of recombinant and nanobody formats, rising focus on assay sensitivity and accuracy, increasing automation in laboratory workflows. Major trends in the forecast period include increasing demand for high-specificity research antibodies, rising use of his-tag antibodies in protein purification, growing adoption of recombinant antibody formats, expansion of tagged protein expression studies, enhanced focus on reproducibility in life science research.

The growing demand for biopharmaceuticals is expected to drive the expansion of the histidine tag (His-Tag) antibody market in the coming years. Biopharmaceuticals are therapeutic products produced using biological sources or biotechnology methods rather than traditional chemical synthesis. This demand is rising due to the increasing prevalence of chronic and complex diseases, which creates a need for advanced targeted therapies that conventional drugs cannot effectively address. Histidine tag (His-Tag) antibodies play a key role in biopharmaceutical research by enabling precise detection and purification of recombinant proteins, making them essential for drug development and therapeutic protein production. They enhance research efficiency and bioprocess reliability by reducing experimental errors through high specificity and reproducibility. For example, in June 2025, the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, reported that prescription drug spending increased by 11.4% in 2023 to $449.7 billion, up from 7.8% growth in 2022. Consequently, the rising demand for biopharmaceuticals is fueling growth in the histidine tag (His-Tag) antibody market.

Leading companies in the histidine tag (His-Tag) antibody market are focusing on developing advanced products, such as automated biosensor-based His-tag quantification kits, to accelerate and standardize protein detection from crude and purified samples. Automated biosensor-based His-Tag quantification kits are commercial assay systems that use biosensor technology to detect and measure His-tagged proteins automatically. For instance, in November 2025, HexagonFab Limited (trading as Abselion), a UK-based life sciences tools company, launched the Tagged Protein Quantification Kit or His-tag and Tagged Protein Sensor for His-tag Quantification. Designed for the Amperia platform and developed using GenScript’s THE His Tag monoclonal antibodies, the kit provides a rapid, mix-and-read, antibody-free method for quantifying His-tagged proteins directly in crude samples. When used with Abselion's Amperia biosensors, it enables real-time, label-free analysis, streamlining protein characterization workflows without requiring multiple instruments. The system is designed to accelerate expression screening, bioprocess optimization, and quality control by providing reliable His-tagged protein measurements without specialist training.

In December 2023, Danaher Corporation, a US-based biotechnology company, acquired Abcam plc for $5.7 billion. Through this acquisition, Danaher aims to strengthen its position in the life sciences and proteomics markets, expanding its portfolio of research reagents, antibodies, and related solutions for drug discovery and diagnostics. Abcam plc, based in the UK, produces His-Tag antibodies used for detecting and purifying recombinant proteins.

Major companies operating in the histidine tag (his-tag) antibody market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Bio-Rad Laboratories Inc., GeneTex Inc., Bio-Techne Corporation, GenScript Biotech Corporation, Sino Biological Inc., Cell Signaling Technology Inc., Wuhan Elabscience Biotechnology Co. Ltd., ABclonal Technology Co. Ltd., Proteintech Group Inc., Santa Cruz Biotechnology Inc., Rockland Immunochemicals Inc., Creative Diagnostics Inc., Aviva Systems Biology Corporation, Abnova Corporation, Boster Biological Technology Co. Ltd., Columbia Biosciences Corporation, NSJ Bioreagents.

North America was the largest region in the histidine tag (His-Tag) antibody market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the histidine tag (his-tag) antibody market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the histidine tag (his-tag) antibody market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the his-tag antibody market by increasing costs of imported antibodies, enzymes, assay kits, purification resins, and laboratory consumables used in protein research workflows. Academic institutions and biotechnology companies in North America and Europe are most affected due to reliance on specialized imported reagents, while Asia-Pacific faces cost pressure on export-oriented antibody production. These tariffs can elevate research expenses and extend procurement timelines. However, they also encourage local antibody manufacturing, regional reagent supply development, and increased adoption of recombinant antibody technologies.

The histidine tag (his-tag) antibody market research report is one of a series of new reports that provides histidine tag (his-tag) antibody market statistics, including histidine tag (his-tag) antibody industry global market size, regional shares, competitors with a histidine tag (his-tag) antibody market share, detailed histidine tag (his-tag) antibody market segments, market trends and opportunities, and any further data you may need to thrive in the histidine tag (his-tag) antibody industry. This histidine tag (his-tag) antibody market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Histidine tag (His-Tag) antibody is a specialized antibody that selectively binds to the histidine tag, a short sequence of histidine residues genetically added to recombinant proteins. It allows researchers to efficiently identify, isolate, and analyze His-tagged proteins with high specificity in molecular and biochemical studies.

The main product types of histidine tag (His-Tag) antibody include monoclonal antibodies, polyclonal antibodies, recombinant antibodies, nanobodies, and other variants. Monoclonal antibodies are highly specific antibodies derived from a single clone and are used for the accurate detection of His-tagged recombinant proteins. They are applied in techniques such as western blotting, immunoprecipitation, flow cytometry, and more, supporting end-users in pharmaceutical and biotechnology R&D, academic research, and contract research organizations.

The histidine tag (His-Tag) antibody market consists of sales of primary antibodies, secondary antibodies, antibody conjugates, antibody kits, and purification resins. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.